Citigroup

Selected news for the capital firm - Citigroup, collected since 10/2017. This capital firm shares healthcare news with Medical Research, Wolfe Research, UnitedHealth, UnitedHealth Group, CVS Health and hundreds of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
1/12/2022 Charles River Laboratories International, Inc. (NYSE:CRL) Receives $412.69 Consensus Target Price from Analysts - Mayfield Recorder Mayfield Recorder ... buy rating to the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $412.69.Several brokerages recently weighed in on CRL. Citigroup dropped their price target on shares of Charles River Laboratories International from $425.00 to $400.00 and set a “neutral” rating on the stock in a research report on Thursday, November 4th. Morgan Stanley dropped ...
1/12/2022 The Kane Republican kanerepublican.com Earnings season begins this week as corporations report their Q4 results and wrap up fiscal year 2021. Related Stocks: Charles River Laboratories Intl Citigroup Darden Restaurants Etsy Inc Ford Motor Fortinet Inc Kraft Heinz Company LKQ Corp Lamb Weston Holdings Inc MGM Resorts International Meta Platforms, Inc. Netflix Solaredge Tech Under Armour Wal-Mart Stores, Inc ...
1/12/2022 The Best and Worst of Q4 Earnings post-gazette.com Earnings season begins this week as corporations report their Q4 results and wrap up fiscal year 2021. Related Stocks: Charles River Laboratories Intl Citigroup Darden Restaurants Etsy Inc Ford Motor Fortinet Inc Kraft Heinz Company LKQ Corp Lamb Weston Holdings Inc MGM Resorts International Meta Platforms, Inc. Netflix Solaredge Tech Under Armour Wal-Mart Stores, Inc ...
1/12/2022 The Best and Worst of Q4 Earnings buffalonews.com Earnings season begins this week as corporations report their Q4 results and wrap up fiscal year 2021. Related Stocks: Charles River Laboratories Intl Citigroup Darden Restaurants Etsy Inc Ford Motor Fortinet Inc Kraft Heinz Company LKQ Corp Lamb Weston Holdings Inc MGM Resorts International Meta Platforms, Inc. Netflix Solaredge Tech Under Armour Wal-Mart Stores, Inc ...
1/12/2022 The Best and Worst of Q4 Earnings financialcontent.com Earnings season begins this week as corporations report their Q4 results and wrap up fiscal year 2021. Related Stocks: Charles River Laboratories Intl Citigroup Darden Restaurants Etsy Inc Ford Motor Fortinet Inc Kraft Heinz Company LKQ Corp Lamb Weston Holdings Inc MGM Resorts International Meta Platforms, Inc. Netflix Solaredge Tech Under Armour Wal-Mart Stores, Inc ...
1/12/2022 Sanford C. Bernstein Raises CVS Health (NYSE:CVS) Price Target to $116.00 dispatchtribunal.com ... a report on Thursday, November 4th. Tigress Financial increased their price objective on CVS Health from $108.00 to $122.00 and gave the stock a buy rating in a research note on Thursday, December 23rd. Citigroup upped their target price on CVS Health from $98.00 to $111.00 and gave the stock a buy rating in a research report on Thursday, November 4th. They noted that the move was a valuation call ...
1/12/2022 Illumina (NASDAQ:ILMN) Shares Gap Up Following Analyst Upgrade etfdailynews.com ... a “neutral” rating on the stock in a report on Monday, November 8th. TheStreet downgraded Illumina from a “b-” rating to a “c” rating in a report on Wednesday, October 6th. Citigroup dropped their target price on Illumina from $450.00 to $400.00 and set a “neutral” rating on the stock in a report on Thursday, January 6th. Bank of America upgraded Illumina from an “underperform” ...
1/12/2022 Hologic, Inc. (NASDAQ:HOLX) Expected to Earn Q1 2023 Earnings of $0.83 Per Share - Stock Observer thestockobserver.com ... the topic of several other reports. Morgan Stanley increased their target price on Hologic from $75.00 to $76.00 and gave the stock an “equal weight” rating in a report on Tuesday, November 2nd. Citigroup downgraded Hologic from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $85.00 to $78.00 in a research report on Wednesday, December 15th. William Blair restated ...
1/12/2022 Gossamer Bio (NASDAQ:GOSS) Downgraded to “Sell” at Zacks Investment Research Daily Political ... research report on Monday, October 18th. SVB Leerink upped their price objective on Gossamer Bio from $15.00 to $16.00 and gave the company an outperform rating in a research report on Tuesday, November 9th. Citigroup upgraded Gossamer Bio from a neutral rating to an outperform rating and set a $24.00 price objective on the stock in a research report on Monday. Finally, Sumitomo Mitsui Financial Group upgraded Gossamer Bio from ...
1/12/2022 Decibel Therapeutics (NASDAQ:DBTX) Upgraded to Hold at Zacks Investment Research - Ticker Report Ticker Report ... a $21.00 price objective for the company. Jonestrading started coverage on Decibel Therapeutics in a report on Thursday, December 2nd. They issued a buy rating and a $25.00 price objective for the company. Finally, Citigroup decreased their price objective on Decibel Therapeutics from $29.00 to $20.00 and set a buy rating for the company in a report on Thursday, November 11th. One research analyst has rated the stock with a ...
1/12/2022 Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Position Increased by Victory Capital Management Inc. - Ticker Report Ticker Report ... Inc.’s holdings in Marinus Pharmaceuticals were worth $1,164,000 as of its most recent filing with the SEC.Several other institutional investors have also recently added to or reduced their stakes in the company. Citigroup Inc. grew its position in shares of Marinus Pharmaceuticals by 32.8% during the second quarter. Citigroup Inc. now owns 5,629 shares of the biopharmaceutical company’s stock worth $101,000 after acquiring an additional 1,390 shares ...
1/12/2022 Want to Collect $300 Each Month While Diversifying? Invest $88,190 in These 3 Stocks | Nasdaq Nasdaq ... without putting all your eggs -- and dividend income -- in one basket. The key is finding businesses with solid financials and safe payouts.Three stocks that fit that criteria are Medical Properties Trust (NYSE: MPW) , Citigroup (NYSE: C) , and Western Union (NYSE: WU) . And with all of them paying dividends at different intervals, investing in all three can ensure that you've got recurring income coming into your portfolio each month of ...
1/11/2022 CVS Health (NYSE:CVS) Raised to “Buy” at Edward Jones - American Banking News American Banking News ... the company. The Goldman Sachs Group assumed coverage on shares of CVS Health in a report on Tuesday, December 14th. They issued a “buy” rating and a $121.00 target price for the company. Citigroup increased shares of CVS Health from $98.00 to $111.00 and gave the stock a “buy” rating in a report on Thursday, November 4th. They noted that the move was a valuation call. Seaport Global ...
1/11/2022 Centene (NYSE:CNC) Price Target Increased to $108.00 by Analysts at Sanford C. Bernstein - American Banking News American Banking News ... Wednesday, November 3rd. BMO Capital Markets raised their price target on shares of Centene from $93.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday, December 13th. Citigroup lowered shares of Centene from a “buy” rating to a “neutral” rating and set a $77.00 price target for the company. in a research report on Monday, November 1st. Finally, Wells Fargo & Company ...
1/11/2022 Charles River Laboratories International (NYSE:CRL) Releases FY22 Earnings Guidance zolmax.com ... November 16th. Zacks Investment Research cut Charles River Laboratories International from a buy rating to a hold rating and set a $458.00 price objective for the company. in a report on Wednesday, September 15th. Citigroup dropped their target price on Charles River Laboratories International from $425.00 to $400.00 and set a neutral rating on the stock in a report on Thursday, November 4th. Finally, Robert W. Baird restated a buy ...
1/11/2022 Zacks Investment Research Lowers Health Catalyst (NASDAQ:HCAT) to Hold etfdailynews.com ... on the stock. Jefferies Financial Group began coverage on Health Catalyst in a research note on Wednesday, December 1st. They issued a “hold” rating and a $48.00 price objective on the stock. Finally, Citigroup cut their price objective on Health Catalyst from $68.00 to $55.00 and set a “buy” rating on the stock in a research note on Monday, December 20th. Two investment analysts have rated the stock ...
1/11/2022 Zacks Investment Research Lowers Health Catalyst (NASDAQ:HCAT) to Hold - Mayfield Recorder Mayfield Recorder ... They issued a “hold” rating and a $48.00 price objective on the stock. SVB Leerink reiterated a “buy” rating on shares of Health Catalyst in a research report on Sunday, September 26th. Citigroup cut their price objective on shares of Health Catalyst from $68.00 to $55.00 and set a “buy” rating on the stock in a research report on Monday, December 20th. Finally, BTIG Research started coverage ...
1/11/2022 Medtronic (NYSE:MDT) Rating Lowered to Neutral at BTIG Research dispatchtribunal.com ... several other reports. Royal Bank of Canada began coverage on shares of Medtronic in a research report on Thursday, December 9th. They issued an outperform rating and a $140.00 target price for the company. Citigroup lowered their price objective on shares of Medtronic from $153.00 to $146.00 and set a buy rating for the company in a research report on Wednesday, November 24th. Oppenheimer lowered their price objective on shares ...
1/11/2022 CS Disco (NYSE:LAW) Stock Rating Lowered by Zacks Investment Research - Mayfield Recorder Mayfield Recorder ... management for enterprises, law firms, legal services providers and governments. CS Disco Inc. is based in AUSTIN, Texas. “Get CS Disco alerts: A number of other brokerages have also issued reports on LAW. Citigroup decreased their price objective on CS Disco from $74.00 to $71.00 and set a “buy” rating for the company in a report on Wednesday, November 10th. Piper Sandler started coverage on CS Disco in ...
1/11/2022 CS Disco (NYSE:LAW) Stock Rating Lowered by Zacks Investment Research - Slater Sentinel slatersentinel.com ... of CS Disco from a “hold” rating to a “buy” rating and cut their price target for the stock from $60.00 to $50.00 in a research note on Thursday, January 6th. Finally, Citigroup cut their price target on shares of CS Disco from $74.00 to $71.00 and set a “buy” rating for the company in a research note on Wednesday, November 10th. One equities research analyst has ...